Task A03: In Vitro Screening for Antibacterial Activity Against Biodefense and Emerging Infectious Disease Pathogens

任务 A03：针对生物防御和新出现的传染病病原体的抗菌活性的体外筛选

• 批准号: 9928533
• 负责人: RICHARD SLAYDEN
• 金额: $ 15.74万
• 依托单位: COLORADO STATE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-01-15 至 2020-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9928533
• 关键词: Advanced Development; Anthrax disease; Anti-Bacterial Agents; Antifungal Agents; Antimicrobial Resistance; Bacillus anthracis; Bacteria; Biological Assay; Burkholderia mallei; Burkholderia pseudomallei; Contracts; Development; Emerging Communicable Diseases; Francisella; In Vitro; Maintenance; Mycotoxins; Toxin; Tularemia; Yersinia pestis; biodefense; combat; fungus; in vitro testing; pathogen; screening; therapeutic development

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

该合同提供潜在抗菌和抗真菌剂的体外测试、对抗细菌和真菌产生的毒素影响的功效、细菌、真菌和毒素库存的维护以及相关测定的开发。